Cite
HARVARD Citation
Joshua, A. et al. (2022). Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER. European journal of cancer. pp. 285-295. [Online].